IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cutter Capital Management, LP

Q2 2024 Holdings

Filed 2024-08-14 | 27 holdings | $331.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$22.5M273,5336.8%
Merck & Co Inc(MRK)COM58933Y105$21.7M175,6006.6%
Gilead Sciences Inc(GILD)COM375558103$20.1M292,9596.1%
Amgen Inc(AMGN)COM031162100$20.1M64,2016.1%
Royalty Pharma PLC(RPRX)SHS CLASS AG7709Q104$18.3M692,3005.5%
Biogen Inc(BIIB)COM09062X103$17.8M76,7265.4%
Kenvue Inc(KVUE)COM49177J102$17.5M960,4005.3%
Insmed Inc(INSM)COM PAR $.01457669307$15.3M227,6374.6%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$15.2M343,1304.6%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$15.0M365,0004.5%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$14.8M911,9004.5%
Sarepta Therapeutics Inc(SRPT)COM803607100$14.1M89,3794.3%
Cytokinetics Inc(CYTK)COM NEW23282W605$12.8M236,9003.9%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$12.2M1,975,2983.7%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$10.9M201,4973.3%
Arcellx Inc(ACLX)COMMON STOCK03940C100$10.3M187,0003.1%
Avadel Pharmaceuticals PLCCOM SHSG29687103$10.3M733,0013.1%
Harmony Biosciences Hldgs in(HRMY)COM413197104$8.9M295,7712.7%
Avantor Inc(AVTR)COM05352A100$8.5M400,0002.6%
Vera Therapeutics Inc(VERA)CL A92337R101$8.3M230,0002.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$7.9M311,7002.4%
Ionis Pharmaceuticals Inc(IONS)COM462222100$7.6M160,1662.3%
Enliven Therapeutics Inc(ELVN)COM29337E102$5.2M222,9851.6%
Pfizer Inc(PFE)COM717081103$5.2M185,2001.6%
Evolus Inc(EOLS)COM30052C107$5.0M465,3001.5%
Sarepta Therapeutics Inc(SRPT)CallCOM803607100$3.2M20,0001.0%
Perrigo Co PLC(PRGO)SHSG97822103$2.6M100,0000.8%